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Abstract
Poisoning by organophosphates (OPs) takes one of the leading places in the total 
number of exotoxicoses. Detoxication of OPs at the first stage of the poison entering the 
body could be achieved with the help of DNA- or RNA-aptamers, which are able to 
bind poisons in the bloodstream. The aim of the research was to develop an approach to 
rational in silico design of aptamers for OPs based on the example of paraoxon. From 
the published sequence of an aptamer binding organophosphorus pesticides, its three-
dimensional model has been constructed. The most probable binding site for paraoxon 
was determined by molecular docking and molecular dynamics (MD) methods. Then 
the nucleotides of the binding site were mutated consequently and the values of free 
binding energy have been calculated using MD trajectories and MM-PBSA approach. 
On the basis of the energy values, two sequences that bind paraoxon most efficiently 
have been selected. The value of free binding energy of paraoxon with peripheral 
anionic site of acetylcholinesterase (AChE) has been calculated as well. It has been 
revealed that the aptamers found bind paraoxon more effectively than AChE. The 
peculiarities of paraoxon interaction with the aptamers nucleotides have been analyzed. 
The possibility of improving in silico approach for aptamer selection is discussed.
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1. Introduction
Organophosphates (OPs) are widely used in agriculture and industry as pesticides, 
plasticizers, components of medicines, polymeric materials, and can be used as 
chemical weapon as well (Costa, 2006; Pope et al., 2005; Rousseau et al., 2000; 
Pitschmann, 2014). That is why poisoning by OPs has been taking one of the leading 
places in the total number of exotoxicoses (Dharmani and Jaga, 2005; Peter et al., 
2010). Since the main mechanism of OPs is inhibition of acetylcholinesterase (AChE), 
the existing approaches of therapy for acute poisoning are reduced to eliminating the 
effects of OPs on AChE (Kaur et al., 2014; King and Aaron, 2015). Such approaches do 
not always prevent the irreversible effects of poisoning. Even in the case of survival, 
injured patients may experience a delayed pathology: so-called "intermediate 
syndrome"; central peripheral distal sensory-motor axonopathy; symptoms of vegetative 
changes in cardiovascular system; "microorganism disorders" of the central nervous 
system of unclear etiology; etc. (Lotti et al., 1993; Ray, 1998; Radilov et al., 
2009;Goncharov et al., 2017). The effectiveness of the existing antidotal, symptomatic 
and preventive therapy can be significantly increased by increasing the detoxification of 
OPs at the first stage of entry of the poison into the body - in the bloodstream, which 
will reduce the toxic effect of OPs on the AChE of neuromuscular and neuronal 
synapses. High-affinity binding of OPs in the bloodstream could be achieved using 
DNA or RNA aptamers, which are short strands of oligonucleotides (Ku et al., 2015). 
Aptamers per se are nucleotide analogues of antibodies, but the process of synthesis of 
aptamers is much simpler and cheaper (Conrad et al., 1996; Kulbachinskiy, 2007). 
Aptamers are not attacked by the immune system and are non-toxic (Bouchard et al., 
2010). All these properties make aptamers the ideal candidates for therapeutic purposes. 
At present, the main method of selection of aptamers is the method of systematic 
evolution of ligands by exponential enrichment (SELEX). The process is based on the 
stepwise selection and amplification of oligonucleotide sequences having the maximum 
affinity for a target molecule (Hüttenhofer and Vogel 2006; Stoltenburg et al., 2007; 
Wang et al., 2012). A huge number of aptamers capable of binding various inorganic 
and organic molecules, proteins and whole cells have been selected so far (Ku et al., 
2015). However, relatively few studies have been devoted to identification of nucleotide 
biosensors for OPs; only the aptamers for four organophosphorus pesticides (forate, 
profenophos, isocarbophos, omethoate) and for the insecticide malathion have been 
found (Wang et al., 2012; Zhang et al., 2014; Williams et al., 2014). The main difficulty 
in selection of aptamers for OPs is due to the fact that molecules of OPs are structurally 
similar, which makes it difficult to choose an aptamer that not only binds a molecule of 
organophosphate but also binds it with high specificity, which could be important in the 
case of a contact with a particular insecticide used in agriculture or with a nerve agent 
to be expected with high probability in the case of a terrorist attack. There are 
difficulties in the methodology of selection, due to the fact that molecules of aptamers 
are several times larger than molecules of OPs. This can lead to high level interference 
during the process of detection. Therefore, only sensitive methods are able to detect 
interaction of aptamers with molecules of OPs, such as plasmon resonance, isothermal 
titration calorimetry and capillary electrophoresis. However, each of the sensitive 
methods has its own set of restrictions and cannot always be applied.
The methods of molecular modeling could replace SELEX and avoid the difficulties of 
this approach. For example, Ashrafuzzaman et al. (2013) attempted to construct a DNA 
aptamer for phosphatidylserine using in silico tools. They used a method similar to the 
SELEX approach: for each of the four possible nucleotides, the probability of its 
interaction with phosphatidylserine molecule was calculated, the most probable pairing 
was chosen, then again the probabilities of interaction of the ligand-nucleotide pair 
obtained at the previous stage with four nucleotides were calculated, etc. Shcherbinin et 
al. (2015) applied an in silico approach to find an aptamer for cytochrome P450. Having 
constructed 64 possible sequences of three nucleotides, the authors performed molecular 
docking of these sequences into the protein binding site and selected the most 
effectively binding triplets. However, the approaches described have a restriction: they 
can only find the binding fragment of the aptamer, and it is not possible to determine the 
structure of the whole aptamer. In the work (Shcherbinin et al., 2015) the non-binding 
part of the aptamers for cytochrome P450 were constructed based on the structure of the 
aptamer for thrombin determined earlier by SELEX. The combination of experimental 
and modeling methods, e.g. the improvement of experimentally obtained aptamers by in 
silico tools, could be a solution to the problem. 
Such combination has been successfully applied by Hsieh et al. (2017) to determine the 
aptamers for prostatic specific antigen (PSA). Having taken five known aptamers for 
PSA as the basis, the authors applied the so-called genetic algorithm: "crossing-over" 
(exchange of nucleotides between sequences) and mutations (replacement of 
nucleotides in the same sequence). As a result, the sequences of the "next generation" 
were created, which bind PSA more efficiently and selectively than the original 
aptamers obtained by the SELEX method. 
In the present work, we have applied for the first time the rational in silico design of the 
aptamer for OPs based on known experimental data on the example of paraoxon. 
According to the published sequence of an aptamer binding organophosphorus 
pesticides (Wang et al., 2012; Zhang et al., 2014), we have constructed a three-
dimensional model of the aptamer, determined the most probable binding site, and by 
mutating gradually the nucleic acids of the site, found the sequences binding the 
paraoxon molecule with the highest affinity.
2. Materials and methods
2.1 Building of 3D-structure of aptamer
The tertiary structure of the initial aptamer, consisting of 35 nucleotides, was 
constructed using an approach similar to one described by Bruno et al. (2008). The 
aptamer was constructed step by step on the basis of segments of its known secondary 
structure (Zhang et al., 2014) using HyperChem software (Froimowitz, 1993):
Duplex 5’-A1GCT-3’ : 5’-A32GCT-3’
Pin 5’-T5G-3’
Duplex 5’-C7TG-3’ : 5’-C29AG-3’
Pin 5’-C10A-3’ : 5’-C27A-3’
Duplex 5’-G12CGAT-3’ : 5’-A22TCGC
Pin 5’-T17CTTG-3’
After construction of each segment, the structure was optimized by energy minimization 
using the conjugate gradient method (Fletcher, 1964). Then the next segment was added 
to the constructed fragment of the aptamer, etc. The final structure was optimized by 10 
ns molecular dynamic simulation and then optimized by energy minimization using the 
conjugate gradient method. The details of all MD simulations are described in section 
2.4.
2.2 Molecular docking of paraoxon into aptamer binding sites and peripheral anionic 
site of acetylcholinesterase
Molecular docking of paraoxon into aptamer binding sites and peripheral anionic site 
(PAS) of acetylcholinesterase (AChE) was performed using Autodock 4.2 software 
(Morris et al., 1998). The structure of the aptamer obtained in the previous step was 
used as its 3D-model. The phosphate groups of the nucleotides of the aptamers were 
assumed to be single deprotonated, while the 5’-end nucleotide was assumed to be 
double protonated, giving the total charge of the aptamers equal to -36. The structure 
4m0e (Cheung et al., 2013) of human AChE from a PDB database (Berman et al., 2000) 
was used as a 3D-model of AChE. The total charge of AChE is -10. The water 
molecules were deleted from the structure, and the missing hydrogen atoms were added 
using Gromacs 5.0.4 (Berendsen et al., 1995) software package. In the studied binding 
sites, an approximation grid of size 60 nodes in x-, y-, and z-directions and with a step 
of 0.0375 nm was constructed. Estimated energy of binding (ΔG) was used to calculate 
the optimum conformations, with dissociation constant (Kd) calculated using this value 
and the formula (Morris et al., 1998). The Lamarckian genetic algorithm for searching 
the optimal conformations was used (Morris et al., 1998). The search procedure was 
repeated 50 times for each protein-ligand pair, which resulted in 50 optimal 
conformations. For each of the binding sites, the conformation with the minimal Kd was 
selected as the final one and used as the starting structure for further molecular 
dynamics simulation.
2.3. Mutation of nucleotides of the aptamer
Mutation of nucleotides in the three-dimensional structure of the aptamer was performed 
using Discovery Studio Visualizer software (BIOVIA, 2016). The tool 
“Build and Edit Nucleic Acid” was used, which allows one to automatically build or 
change a nucleotide according to the standard topology, then to save a new structure in 
pdb-format.
2.4. Molecular dynamics simulation of free aptamer, paraoxon-aptamer and paraoxon-
AChE complexes
Conformational changes of paraoxon-aptamer and paraoxon-AChE complexes were 
calculated by the MD method using the Gromacs 5.0.4 (Berendsen et al., 1995) software 
package and CHARMM force field (Zhu et al., 2012). The topology file for paraoxon is 
available in the Supplementary material (paraoxon-charmm.docx). The parameters for 
all the bonds, angles and dihedrals of paraoxon are already included in the CHARMM 
force field; 22 files of the force field parameters are available at 
http://mackerell.umaryland.edu/download.php?filename=CHARMM_ff_params_files/c 
harmm36-jul2017.ff.tgz. The complexes obtained by molecular docking were placed 
virtually into a cubic periodic box filled with water molecules. The TIP3P model was 
used to describe water molecules (Jorgensen et al., 1983). To neutralize a system, 36 or 
10 sodium ions were added to aptamers-paraoxon and AChE complexes respectively. 
Simulations were performed at a temperature of 300 K and a pressure of 1 bar. 
Temperature and pressure were kept constant using a V-rescale thermostat (Bussi et al., 
2007) and a Berendsen barostat (Berendsen, 1984), with coupling constants of 0.1 ps 
and 1.0 ps, respectively. Long-range electrostatic interactions were treated by the 
particle-mesh Ewald method (Darden, 1993). Lennard-Jones interactions were 
calculated with a cut off of 1.0 nm. The LINCS algorithm was used to constrain bonds 
length. Before running the MD simulations, all the structures were minimized by 
steepest descent energy minimization (Jensen, 2010) and equilibrated with 100 ps MD 
simulation. 10 ns MD simulation with the time step 0.002 ps was performed to optimize 
the three-dimensional structure of the aptamer. 2 ns MD simulation with the time step 
0.0005 ps was performed to check stability of paraoxon-aptamer complexes. 10 ns MD 
simulation with the time step 0.002 ps was performed to simulate conformational 
changes of the complexes of paraoxon with AChE and of the complexes of paraoxon 
with the chosen binding site (site-1) of the aptamers.
2.5.Calculation offree binding energy of paraoxon-aptamer and paraoxon-AChE 
complexes.
Free binding energies of the obtained complexes were calculated using the MM-PBSA 
method (Genheden and Ryde, 2015) with the help of g_mmpbsa application (Kumari et 
al., 2014) integrated into the Gromacs software package. The MM-PBSA method 
enables estimating of energy of receptor-ligand complex formation on the base of MD 
trajectories. Free binding energy ΔGbind is calculated by the formula:
ΔGbind = GRL – (GR + GL) (eq. 1),
whereG is free energy, the index R refers to receptor, L – to ligand, RL – to receptor-
ligand complex. Free energy of a molecule or a complex is calculated by the formula 
(2):
GX= EMM+Gsolv-TSMM (eq. 2),
where the index X refers to a receptor, a ligand or their complex, EMM is potential 
energy of a molecule or a complex in vacuum calculated by molecular mechanics 
method, Gsolv is free energy of solvation, TS is the entropy component of free energy of 
a system in vacuum, T and S are temperature and entropy respectively.
Free energy of solvation is calculated by the formula:
Gsolv = Gpolar + Gnon-polar (eq. 3),
whereGpolar and Gnon-polar  are the contributions of polar and nonpolar interactions, 
respectively, to free energy of solvation. EMM is calculated as the sum of covalent, van 
der Waals and electrostatic interactions.
Previous studies have showed that entropy value fluctuates greatly during MD 
simulation. It was shown that the calculation of the enthalpy component correlates 
better with the experimental data than the calculation of the total free energy (Kumari et 
al., 2014). Therefore, in our work we calculated the enthalpy component of free energy 
only.
In the work presented, we calculated the values of free energies every 1 ps during MD 
simulation.Thus, the result of every g_mmpbsa run was 10000 values of free energy. 
The final value was calculated as the mean ± standard deviation; g_mmpbsa uses kJ/mol 
as energy units. The obtained energy values were converted to kcal/mol.
3. Results
3.1 Building the 3D-structure of aptamer
In the work of Zhang et al. (2014), several DNA aptamers for four organophosphorus 
pesticides (isocarbophos, profenophos, omethoate, and phorate) were obtained by the 
SELEX method. Among the compounds, the structures of profenophos and 
isocarbophos are the most similar to the structure of paraoxon. The aptamer SS24-S-35, 
which has the highest affinity for profenophos and isocarbophos, has the following 
primary sequence:
5’-AGCTTGCTGC10AGCGATTCTT20GATCGCCACA30GAGCT-3’
Based on the secondary structure of the aptamer (Zhang et al., 2014), we have 
constructed its three-dimensional model and optimized the resulting structure by 10 ns 
MD simulation in solution. The change of root-mean-square deviation (RMSD) of 
atomic positions in time has been calculated. The value of RMSD increases during the 
first 3 ns of the simulation then remains unchanged during the last 7 ns, which indicates 
stability of the structure. The final conformation of the aptamer was optimized by 
energy minimization. The final model is shown in Fig. 1.
3.2. Molecular docking of paraoxon into the possible binding centers of the aptamer.
Visual analysis has revealed five nucleotides (C18, A22, C13, A11 and T5) that are 
located at concavities of the obtained 3D structure of the aptamer and could be used as 
the grid centers (grid centers 1-5) for the molecular docking procedure for searching the 
sites where paraoxon could bind. Molecular docking of paraoxon into these five 
possible centers has been revealed five possible binding modes of paraoxon on the 
aptamer surface. We have repeated the search for possible grid centers using the 
following approach. Using g_mmpbsa package, we calculated the contribution of the 
nucleotides to the value of nonpolar solvation energy. Again, the structure of free 
aptamer obtained in section 2.1 was used. The value of nonpolar solvation energy is 
assumed to depend linearly on the value of solvent accessible surface area (Kumari et 
al., 2014). Thus, the nucleotides giving the minimal contribution into the value of 
nonpolar salvation energy have the minimal solvent accessible surface area. It means 
that they are located in the depth of the aptamer and could also be used as the grid 
centers for molecular docking procedure. The calculation of nonpolar solvation energy 
showed that the following nucleotides contribute the least: С18 (ΔGnonpolar = -0.51 kcal/
mol, coincides with grid center 1); А22 (ΔGnonpolar = -0.69 kcal/mol, coincides with grid 
center 2); A32 (ΔGnonpolar = -0.82 kcal/mol, located in 3 Å from grid center 5); С26 
(ΔGnonpolar = -0.82 kcal/mol, located in 4.6 Å from grid center 3); С10 (ΔGnonpolar = -0.95 
kcal/mol, located in 2.6 Å from grid center 4). We have limited ourselves to five 
nucleotides, since five grids with centers at these points completely cover the surface of 
the aptamer. Thus, we have picked three additional grid centers: A32 as grid center 6, 
C26 as grid center 7, and C10 as grid center 8. Three additional molecular docking 
procedures have been performed; the found binding modes 6-8 coincide with binding 
modes 5, 3 and 4 respectively. The final eight positions of the paraoxon molecules in 
sites 1-5 obtained by molecular docking are shown in Fig. 2.
For the complexes obtained, the values of intermolecular energy (sum of energies of van 
der Waals and electrostatic interactions) and the energy of hydrogen bonds and 
desolvation were calculated. In addition to the enthalpy component, the Autodock 
algorithm estimates the change of system entropy based on the amount of "frozen" 
rotating ligand bonds. Based on the values of enthalpy and entropy components, the free 
binding energy is estimated. The nucleotides of the binding sites 1-5, the calculated 
values of intermolecular energy and the estimated values of free binding energy of 
paraoxon with the sites are shown in Table 1.
According to the energy values given in Table 1, site-5 is the most effective for 
paraoxon binding. However, sites-1 and -4 have greater conformational mobility due to 
the fact that they contain unpaired nucleotides. Thus, despite the obtained energy 
values, sites-1 and -4 are the most probable sites of paraoxon binding. To verify this 
hypothesis, the stability of all the complexes obtained was verified by 2ns MD 
simulation. Among the five complexes, only that of paraoxon with site-1 remained 
stable throughout the entire simulation. For the other four complexes, the paraoxon 
molecule became detached from the aptamer and then remained in an unbound state. As 
we anticipated, nucleotides of site-1 have sufficient conformational mobility to adjust to 
the paraoxon molecule. Moreover, in the papers of Wang (2012) and Zhang (2014), the 
authors obtained not only aptamer SS24-S-35 but several aptamers for organophosphate 
pesticides, and all of them contain the same sequence: CTGCAGCGATTCTTGATCG, 
which probably forms the binding site for the pesticides. In the case of the aptamer 
SS24-S-35, only sites-1 and -2 contain this sequence in its entirety. This fact is in 
agreement with the result of MD simulation that showed site-1 to be the most stable 
binding site for paraoxon.
The complex of paraoxon with site-1 after 2 ns of MD simulation became the starting 
structure for further mutations of nucleotides of the binding site, in order to find the 
sequence that binds paraoxon as efficiently as possible. The initial coordinates of 
paraoxon were the same for all the mutants. Hereinafter, for convenience, we use the 
abbreviation PAC (paraoxon-aptamer-complex) for the initial paraoxon-aptamer 
complex, which is the complex of aptamer SS24-S-35 with paraoxon bound in site-1.
3.3Molecular dynamics simulation of the initial paraoxon-aptamer complex (PAC).
Conformational changes of PAC over a longer time interval have been calculated by 10 
ns MD simulation. The complex remained stable throughout the simulation, i.e. the 
paraoxon molecule stayed associated with site-1 of the aptamer (Fig. 3). The final 
conformation of PAC is shown in Fig. 4.
Visual analysis of the complex revealed that the paraoxon molecule is surrounded by 
nucleotides T17, C18, T19 and T20. The benzene ring of the ligand interacts with the 
aromatic ring of nucleotide T19, the phosphorus group of nucleotide T17, and the ethyl 
groups of nucleotides C18 and T20. Visual analysis of the aptamer nucleotides 
fluctuations over time shown that the side chains of nucleotides T17 and T19 do not 
change their conformation during the simulation and strongly interact with the paraoxon 
molecule, while the side chains of C18 and T20 change their positions relative to the 
paraoxon molecule periodically. In the final conformation, C18 is distant from the 
ligand molecule, while T20 is close to it.
On the basis of the trajectory obtained, the value of free binding energy of the complex 
has been calculated to be -31.0 ± 3.8 kcal/mol. The contribution of each of the four 
nucleotides of site-1 to the value of the binding energy has also been calculated; the 
results are shown in Table 2.
The quantitative analysis of the contribution of individual nucleotides to the binding 
energy value (Table 2) coincides with the qualitative visual analysis of the 
conformational changes described above. Nucleotides T20 and C18 contribute 
minimally to the interaction, while T19 and T17 contribute maximally. These data 
explain the result of MD, according to which paraoxon interacts with site-1 more 
weakly than with other possible binding sites (see section 3.2). According to the results 
of MD of paraoxon into the free aptamer, the "weak" nucleotides C18 and T20 are 
closest to paraoxon, and the enhancement of aptamer-paraoxon interaction occurs after 
conformational changes of the oligonucleotide. We therefore decided that it would be 
most rational to start our search for better sequences for binding paraoxon with 
replacement of the more "weak" nucleotides T20 and C18, and to check whether other 
nucleotides in these positions interact more strongly with paraoxon.
3.4 Mutation of nucleotide at position 20.
By virtual replacement of thymine in position 20 with adenine, cytosine or guanine, 
three new variants of the aptamer complex with paraoxon have been obtained: T20A, 
T20C and T20G. Conformational changes of T20A, T20C and T20G have been 
calculated by 10 ns molecular dynamics simulation. T20A and T20C remained stable, 
with paraoxon remaining bound to the aptamers during the entire simulation, T20G 
disintegrated after 6 ns (Fig. 3). The binding energies of the complexes have been 
calculated on the basis of the trajectories obtained, the results are shown in Table 3. 
According to the values obtained, none of the substitutions improved the affinity of the 
aptamer to paraoxon. The replacement of thymine with adenine was equivalent; the 
binding energy of T20A (-30.7 ± 3.9 kcal / mol) was comparable to the value of PAC 
binding energy (-31.0 ± 3.8 kcal / mol). The replacements of thymine with guanine or 
cytosine decreased the affinity. Thus, according to the data obtained, either thymine or 
adenine should be at position 20.
3.5 Mutation of nucleotide at position 18.
As previously (section 3.4), three new variants of the aptamer complex with paraoxon 
were obtained by replacing C18 of PAC with adenine, guanine or thymine: C18A, 
C18G and C18T. Conformational changes of C18A, C18G and C18T have been 
calculated by 10 ns MD simulation. C18G and C18T remained stable; paraoxon 
remained bound with the aptamers during the entire simulation, C18A disintegrated 
after 6 ns (Fig. 3). The binding energies of the complexes have been calculated on the 
basis of the trajectories obtained, the results are shown in Table 3. According to the 
values obtained, none of the substitutions improved the affinity of the aptamer to 
paraoxon. The replacement of cytosine with thymine was equivalent: the binding energy 
of C18T (-30.6 ± 3.6 kcal / mol) was comparable to the value to the value of PAC 
binding energy (-31.0 ± 3.8 kcal / mol). The replacements of cytosine with adenine or 
guanine decreased the affinity. Thus, according to the data obtained, either cytosine or 
thymine should be at position 18.
3.6 Mutation of nucleotide at position 19.
As previously (sections 3.4 and 3.5), three new variants of the aptamer complex with 
paraoxon were obtained by replacing T19 of PAC with adenine, cytosine or guanine: 
T19A, T19C and T19G. Conformational changes of T19A, T19C and T19G have been 
calculated by 10 ns MD simulation. All the complexes remained stable; paraoxon 
remained bound with the aptamers during the entire simulation (Fig. 3). The binding 
energies of the complexes have been calculated on the basis of the trajectories obtained, 
the results are shown in Table 3. According to the values obtained, none of the 
substitutions improved the affinity of the aptamer to paraoxon; all the replacements 
decreased the affinity. Thus, according to the data obtained, only thymine should be at 
position 19.
3.7 Mutation of nucleotide at position 17.
As previously (sections 3.4-3.6), three new variants of the aptamer complex with 
paraoxon were obtained by replacing T17 of PAC with adenine, cytosine or guanine: 
T17A, T17C and T17G. Conformational changes of T17A, T17C, and T17G have been 
calculated by 10 ns MD simulation. All the complexes remained stable; paraoxon 
remained bound with the aptamers during the entire simulation (Fig. 3). The binding 
energies of the complexes have been calculated on the basis of the trajectories obtained, 
the results are shown in Table 3. According to the values obtained, the replacements of 
thymine with adenine decreased the affinity. The replacement of thymine with guanine 
was equivalent; the binding energy of T17G -31.3±3.7 kcal/mol) was comparable to the 
value of PAC binding energy (-31.0 ± 3.8 kcal/mol). The replacements of thymine with 
cytosine improved the affinity; the binding energy of Т17С was equal to -32.3±3.0 
kcal/mol. Thus, according to the data obtained, only cytosine should be at position 17.
3.8. Double and triple mutations
At demonstrated in sections 3.5-3.7, we have revealed which single mutations improve 
binding of paraoxon with site-1. Based on the data obtained, we have checked two 
double and one triple mutations of the nucleotides of site-1: T17C-C18T, T17C-T20A 
and T17C-C18T-T20A. The free binding energies of the complexes have been 
calculated by 10 ns MD simulation. All the complexes remained stable; paraoxon 
remained bound with the aptamers during the entire simulation (Fig. 3). The values 
were equal to -32.8 ± 3.1 kcal/mol, -30.6 ± 3.4 kcal/mol and -29.6 ± 3.2 kcal/mol for 
T17C-C18T, T17C-T20A and T17C-C18T-T20A respectively. These data indicate that 
the double mutation T17C-C18T increases the effectiveness of paraoxon binding, 
whereas the mutations T17C-T20A and T17C-C18T-T20A do not.
Thus, according to our calculations, the following two aptamers bind paraoxon most 
effectively:
5’-AGCTTGCTGC10AGCGATCTTT20GATCGCCACA30GAGCT-3’ 
(T17C-C18T, ΔG=-32.8 ± 3.1 kcal/mol)
5’-AGCTTGCTGC10AGCGATCCTT20GATCGCCACA30GAGCT-3 
(Т17С, ΔG=-32.3±3.0 kcal/mol)
It is interesting to compare the values of binding effectiveness of our aptamers with in 
silico and in vivo data on binding properties of aptamers obtained by other researchers. 
According to the data given in Chang et al. (2014), the values of Kd of aptamers with 
small molecules vary in a very high range: from 200 pM to 76 μM. As mentioned 
above, several aptamers for four organophosphate pesticides were obtained by the 
SELEX method (Wang et al., 2012). For two of these aptamers, the Kd values are given 
in the paper, with values varying from 0.83 to 2.5 μM. To understand what Kd we could 
expect from the vales of free binding energies obtained by us, we have turned to the 
work of Shcherbinin et al. (2015), where the binding characteristics of seven aptamers 
for cytochrome p450 were studied both by in silico and in vitro methods. The values of 
the enthalpy term of free binding energy for those seven aptamers, calculated by the 
MM-PBSA method, vary from -54.80 to -14.72 kcal/mol, and the experimentally 
obtained values of Kd vary from 0.14 to 1.3 μM. For three aptamers, the calculated 
values of enthalpy term were -38.86, -37.76 and -36.26 kcal/mol, which is comparable 
with the values obtained in our work (as mentioned above, we have calculated the 
enthalpy term of free biding energy only). For those three aptamers for cytochrome 
p450, the experimental Kd values were 0.4, 0.5 and 0.6 μM, respectively. Therefore, as a 
very rough approximation we can expect the Kd values of our aptamers for paraoxon to 
be around 1 μM.
3.9. Binding of paraoxon with the peripheral anionic site of acetylcholinesterase.
Synaptic acetylcholinesterase (AChE) is the main target of OPs. To estimate the ability 
of the aptamers found to compete with AChE for paraoxon binding, we have 
investigated interaction of paraoxon with the enzyme. It is known that the primary 
binding of ligands occurs in the peripheral anionic site (PAS) of AChE, which includes 
amino acids Tyr72 and Asp74 (numbering for human AChE). We have performed 
molecular docking of the paraoxon molecule into PAS. The complex obtained has then 
been used as the starting conformation for further 10 ns molecular dynamics simulation. 
The change in value of RMSD for the Cα atoms of AChE and for the paraoxon atoms 
relative to the starting conformation have been calculated. The value of RMSD for Cα 
atoms of AChE increased up to 0.2 during the first 2 ns of the simulation, and then 
remained constant for the next 8 ns. The RMSD value for paraoxon atoms increased up 
to 0.2 for the first 100 ps of the simulation, and then remained constant. Visual analysis 
of the position of paraoxon in the PAS showed that the position of the ligand was stable 
throughout the entire simulation; the final conformation of the complex is shown in Fig. 
5.
The atom of phosphoryl oxygen of paraoxon interacts with the NH group of Leu76, the 
benzene ring of the ligand is in the same plane with the aromatic group of Trp286, 
which indicates pi-pi interaction between them. One of the oxygen atoms of the nitro 
group of paraoxon forms a hydrogen bond with the backbone NH group of Asp74.
We have also calculated the free binding energy of AChE-paraoxon complex, which 
was -26.0 ± 2.6 kcal/mol. Thus, according to the data obtained, the aptamers that we 
have found bind paraoxon more efficiently than AChE.
The PAS of AChE is just the primary site for binding of AChE ligands. After binding of 
substrates and irreversible inhibitors with the PAS, conformational changes occur in the 
structure of AChE and ligands quickly penetrate further along the narrow active-site 
gorge towards the catalytic triad, where acetylation or irreversible phosphorylation of 
the catalytic serine occurs. Therefore, there are relatively few studies that distinguish 
ligand binding with the PAS and with the catalytic center. As for OPs, in the work of 
Radić et al. (1991) it was shown that Kd of the complex of PAS with haloxon (an 
organophosphate anthelmintic) equals16 μM. Whilst this is ten-fold greater than our 
roughly estimated Kd for aptamer-paraoxon complexes, at least such a value does not 
contradict our data that the obtained aptamers binds paraoxon better that the PAS of 
AChE does.
Molecular docking procedure has revealed five possible binding sites of paraoxon on 
the aptamer surface. Furthermore, molecular dynamic simulation has shown that only 
site-1 could bind paraoxon molecule effectively though, according to the results of 
docking, the binding in site-1 is the weakest (Table 1). We have proposed that such 
discrepancy could be due to greater conformational mobility of site-1, having five 
unpaired nucleotides. To this proposal, we have performed molecular docking of 
paraoxon into the improved conformational model of the aptamer. From the MD 
simulation of the initial aptamer with paraoxon, we have selected the conformation with 
the best binding energy (ΔG = -45.0 kcal/mol), and then minimized this structure. The 
obtained structure (Confbest) is shown in Fig. 6 in purple and grey. We have performed 
molecular docking of paraoxon into site-1 of the aptamer in this conformation; the 
obtained geometry is shown in Fig. 6 in green. The orientation of the paraoxon 
molecule obtained by docking is close to the one in the complex selected from the MD 
trajectory. The value of intermolecular energy obtained by docking is -5.79 kcal/mol, 
and the estimated value of free binding energy is -3.7 kcal/mol, which is 1.4 kcal/mol 
lower than the value obtained by docking of paraoxon into site-1 of the free relaxed 
aptamer, but still higher than the values for site-4 and 5 (Table 1).
This discrepancy between the results of docking and MM-PBSA can be explained by 
the fact that the empirical scoring function of Autodock estimate binding free energy by 
summing interaction terms derived from weighted structural parameters. The weights 
are obtained by fitting the scoring function to experimental binding constants of a 
training set of receptor-ligand complexes. Probably, such kind of parameterization is 
not ideal for DNA as a receptor. Also, Autodock does not take into account flexibilities 
of receptor-ligand complexes. The MM-PBSA method uses a force field based scoring 
function, and the main advantage of the g_mmpbsa module is that it takes several 
hundred snapshots of the free binding energy values from MD trajectory, which makes 
it possible to estimate the interaction properties with better approximation. But still, 
molecular docking can be used to determine the geometry of binding mode at a 
particular moment of time, which could be further evaluated by MD simulation.
It is interesting to compare the MM-PBSA approach and the linear interaction energy 
(LIE) method, which is an alternative method for free binding energy calculation 
(Åqvist et al. 1994). The LIE method postulates that the free energy of binding ∆G is 
linearly correlated to both van der Waals and electrostatic interactions between the 
ligand and the rest of the system. The LIE equation is known as:
∆G= α∆Evdw+ β∆Eelec+ γ (eq. 4),
where ∆Evdw and ∆Eelec are the changes in van der Waals and electrostatic energy from 
the ligand free and bound state. The α, β and γ are LIE empirical parameters, 
determined by comparing calculated and experimentally estimated binding affinities. 
MM-PBSA principles are described in section 2.5 Both approaches have their own 
advantages and disadvantages (Barril et al., 2001; Genheden, 2011; Genheden and 
Ryde, 2015; Homeyer et al.,2014; Hou et al., 2002; Mikulskis et al., 2012; Perdih et al., 
2013). In the MM-PBSA approach, the solvation free energy is determined by a 
continuum solvent model and a term accounting for the non-polar contribution to 
solvation. Because of that, MM-PBSA needs only one MD simulation for the protein-
ligand complex, whereas two MD simulations for ligands in the bound and free states 
are needed for LIE. This is important because of the inverse correlation between 
calculation accuracy and required computing time. However, the calculations involving 
an estimation of solvation free energies at the macromolecular level can lead to large 
numerical errors. MM-PBSA is based on the general empirical parameters for Poisson-
Bolzman and Surface Area calculations and one does not need to additionally calibrate 
the parameters. Conversely, the LIE method is highly system dependent and the 
optimization of the parameters can be required. When using MM-PBSA, one has to 
always decide whether to include the entropy or not. As it was mentioned above, the 
calculation of the enthalpy component correlates better with the experimental data than 
with the calculation of the total free energy. Hence, it seems reasonable to omit the 
entropy at a first stage for a ligand-receptor complex. Free energy changes produced by 
linear response models implicitly include conformational entropy effects through the 
linear response expressions, which relate potential energy differences to free-energy 
differences. It should be mentioned that the MM-PBSA method gives a large range of 
estimated affinities, while LIE gives results within a more reasonable range. Concluding 
the comparison of two approaches, it is possible to say that MM-PBSA is a reasonable 
choice for our calculations: (1) no additional parameterization for DNA as a receptor is 
needed and (2) the continuum solvent model reduced computation time greatly for more 
than twenty MD simulations performed in the paper.
The purpose of the study was not just to find the best aptamers for paraoxon but also to 
consider the possibility, based on currently available data, of developing the most 
rational approach to selection of aptamers to small molecules. Molecules of such a size 
as paraoxon and other OPs can interact with 3-5 nucleotides, which means that the 
number of possible combinations could vary from 43 to 45, which is 64-1024 variants. In 
the present work, we have tried to optimize the search as much as possible. At the first 
step, we performed all possible single mutations of nucleotides of the original aptamer, 
and then, assuming that "minus" to "minus" does not give "plus" in our case, we studied 
the double and triple mutations that consist of "successful" single mutations only. In this 
approach we still had to test 16 combinations. Of course, we recognize that prescreening 
of effective aptamers by in silico methods could reduce the cost and speed up the 
procedure of bioscavengers selection. Nevertheless, it would be beneficial to optimize 
the prescreening process and to then select effective aptamers based on the chemical 
structure of a ligand. For example, a molecule of paraoxon contains three specific 
groups in its structure. Firstly, the phosphate group with a phosphorus atom having a 
huge positive charge and an oxygen atom having a large negative charge. Secondly, the 
nitro group with a positively charged nitrogen atom and two negatively charged oxygen 
atoms. We could expect that the oxygen atoms of the phosphate and nitro groups would 
form hydrogen bonds with NH-groups of nucleotides and "avoid" other oxygen atoms 
of an aptamer. According to such logic, the ideal neighboring groups would be 
adenosines. Thirdly, the paraoxon molecule contains a benzene ring, which would 
preferentially interact with aromatic groups of nucleotides via pi-pi interaction.
Further to the above theoretical expectations, we now consider the complex of paraoxon 
with the initial aptamer (PAC, Fig. 4). Although PAC is not the best aptamer, according 
to our data it still binds paraoxon better than AChE. It should be noticed that there are 
none of the expected interactions: neither pi-pi interaction between aromatic rings, nor 
hydrogen bonds between oxygen atoms of paraoxon and NH groups of nucleotides.
Fig.7 shows the complexes of paraoxon with the most effective aptamers T17C-C18T 
(Fig. 7a) and T17C (Fig. 7b) that we have obtained.In the case of aptamer T17C, the 
benzene ring does form pi-pi interaction with nucleotide T19 (Fig.7b). However, for the 
complex of paraoxon with aptamer T17C-C18T, neither H-bonds nor pi-pi interaction 
are observed (Fig. 7a). 
Figures 4, 7a and 7b show the complexes of paraoxon with the initial aptamers, aptamer 
T17C and T17C-C18T after 10 ns of MD simulation. It should be noticed that the pose 
of the ligand differs even after only one mutation, which was probably due to the 
different charge distribution in nucleotides. Thus, thymine and cytosine differ from each 
other by one group: the ketone group =O in thymine is replaced by the NH2 group in 
cytosine. This affects the distribution of charges in the nucleotides. We used the 
CHARMM force field for the MD simulations. In this force field, the charge of atom O4 
of thymine equals -0.45, and the charge of atom N4 of the cytosine equal -0.75. The 
charge of atom N1 equal -0.34 in thymine, and -0.13 in cytosine. The charge of atom 
N3 equal -0.46 in thymine, and -0.66 in cytosine. Since the position of paraoxon 
molecule in the complexes with the aptamers is less sterically restricted than if it were 
bound in some deep pocket of a protein like AChE, we suppose that difference in charge 
distribution can lead to such mobility of paraoxon in the binding site of the aptamers.
The conformation of a complex of a small molecule with an aptamer can be determined 
experimentally only by X-ray crystallography or nuclear magnetic resonance 
spectroscopy techniques, which are quite expensive procedures. Only a few dozen of 
such complexes have been published in the PDB database. Therefore, unfortunately, no 
one has tested experimentally how one nucleotide mutation affects the conformation of 
a ligand in aptamer binding sites. The work of Shcherbinin et al. (2015) could be used 
as an indirect confirmation that one mutation can significantly change the binding 
characteristics. The authors performed mutation of the binding moiety of the aptamers 
for cytochrome p450 (in this case the ligand is not a small molecule but a protein) and 
checked by in silico and in vitro methods how the mutation changed the binding 
properties of the aptamers. There were two aptamers in the testing set, differing only by 
one nucleotide (binding triplets CAT and CGT), and the values of dissociation constants 
for their complexes with cytochrome determined experimentally are 0.6 and 0.28 μM, 
respectively, which differ twice.
We have analyzed the contribution of electrostatic and van der Waals terms to 
interaction energy of paraoxon with aptamers T17C-C18T and T17C during the MD 
simulation period. The results are shown in Fig. 8(a-b). In the case of aptamer T17C-
C18T, the value of electrostatic energy begins to increase after 3 ns of simulation from 
negative values to 0, and van der Waals energy decreases (Fig. 8a). An analysis of the 
conformation of paraoxon in the binding site showed that in the time interval from 0 to 
3 ns there is a pi-pi bond between paraoxon and nucleotide T20, then the bond breaks 
and the ligand transforms into a conformation corresponding to the final position (Fig. 
7a). In the case of aptamer T17C, two main conformational states of its complex with 
paraoxon are observed during the simulation too. In the first one, the pi-pi bond is 
formed between paraoxon and the aromatic ring of nucleotide T19. This conformational 
state corresponds to stronger electrostatic interaction and weaker van der Waals 
interaction (periods 0-1 and 6-10 ns of the simulation). In the second conformational 
state, there is no pi-pi interaction between the ligand and the aptamer (period 1-6 ns of 
the simulation). During this period, electrostatic interaction is weaker and van der 
Waals energy is stronger. Thus, for both of the best aptamers, a pi-pi bond between 
paraoxon and nucleotides can exist, though it seems that in aptamer T17C-C18T it is 
weaker and van der Waals interactions are more preferable.
In addition to the analysis of two most effective aptamers, it is interesting to analyze the 
behavior of other oligonucleotides in detail. For additional analysis, we have selected 
two the most ineffective aptamers (C18A and T20G, binding energies are -13.4±16.0 
and -18.1±11.0 kcal/mol, respectively) and two aptamers with an average efficiency 
(T19C and C18G, binding energies are -22.6±6.1 and -26.6±4.6 kcal/mol, respectively). 
Fig. 8(c-f)shows the time dependence of van der Waals and electrostatic energies of the 
aptamers and paraoxon complexes.
After 3.8 ns of simulation of the complex of aptamer C18A and paraoxon, the distance 
between paraoxon and nucleotide A18 starts to increase (Fig. 3), and van der Waals 
energy also begins to increase from negative values towards zero (Fig. 8c). After 6 ns of 
simulation, the distance keeps increasing and electrostatic energy begins to increase too 
until paraoxon is completely detached from the aptamer and the values of interaction 
energies are equal to zero. Analysis of paraoxon behavior has shown that after 3.8 ns, 
the phosphorous moiety of the ligand turns from the nucleotides into solution, and in the 
time interval from 5 to 6.5 ns the paraoxon molecule is bound to the aptamer only via 
pi-pi interaction with the aromatic ring of nucleotide T19. The complex of paraoxon 
with aptamer T20G behaves in a similar way (Fig. 3 and 8d). After 3.8 ns of simulation, 
the phosphorus moiety of the ligand turns into solution and the value of van der Waals 
energy increases. In the time interval between 4.5 to 6.5 ns, paraoxon is bound with the 
aptamer only via pi-pi interaction with the aromatic rings of nucleotides T19 and G20, 
then paraoxon detaches from the aptamer.
It can be seen that in the complex of paraoxon with aptamer T19C the distance between 
the ligand and nucleotide C18 (Fig.3) and van der Waals energy (Fig. 8e) increase at the 
moments 2.2 ns and 8.5 ns, then the values return to the initial ones. At these moments, 
as in the case of aptamers C18A and T20G, the phosphorous moiety of the ligand turns 
into solution, and paraoxon interacts with the aptamer only via pi-pi interaction with 
nucleotide T17, then the phosphorous moiety returns to its initial position. Similar 
behavior is observed for aptamer C18G. At time moments 4.2 ns and 8.5 ns, both the 
distance between paraoxon and nucleotide C18 (Fig.3) and van der Waals energy (Fig. 
8f) increase, then the values return to the initial ones. At these moments, the 
phosphorous moiety of the paraoxon turns into solution, and the ligand interacts with 
the aptamer via pi-pi interaction with nucleotides T19 and T20.
It is noteworthy that in the case of aptamers C18A, T20G and C18G, nucleotide T19 
participates in pi-pi interaction with paraoxon. In the case of aptamer T19C, when 
nucleotide T19 is replaced by cytosine, it is nucleotide T17 that participates in this 
interaction. Thus, thymine is probably preferable to cytosine to form a pi-pi bond with 
paraoxon. Also it can be noted that pi-pi interaction is the last “anchor” for paraoxon 
before detaching from an aptamer molecule. A similar situation probably occurs in the 
opposite direction: before binding, a paraoxon molecule anchors to the aptamers via pi-
pi interaction with one of the nucleotides of the binding site.
It is interesting to compare our observations with other experimental data. There are 
several complexes of aptamers with small molecules analyzed by nuclear magnetic 
resonance (NMR) in the Protein Data Bank (Berman et al., 2000). Unfortunately, there 
are no structures analogous to paraoxon. We have therefore selected the most similar 
structures for analysis: the complex of citrulline with an RNA aptamer (structure code 
1kod, Yang et al., 1996); the complex of arginine with an RNA aptamer (structure code 
1koc, Yang et al., 1996); the complex of two molecules of argininamide with an RNA 
aptamer (structure code 1nbk, Matsugami et al., 2003); and the complex of malachite 
green with an RNA aptamer (structure code 1q8n, Flinders et al., 2004).
The structure of a citrulline molecule contains one COO--group and one amide 
C(O)NH2-group. Analysis of the aptamer-citrulline complex has revealed that these 
groups do not form any specific bonds. The structure of an arginine molecule contains 
two NH2-groups and one COO--group. One of the NH2 groups of the ligand may form a 
hydrogen bond with the aromatic nitrogen atom of one of the cytosines of the aptamer, 
but this is uncertain as some hydrogen atoms are missing in this structure. Furthermore, 
the COO--group of arginine does not form any h-bonds since the distance to the other 
atoms is too great. The structure of an arginineamide molecule contains a COO--group 
and a NH2-group. According to the geometry of an aptamer complex with two 
argininamides, COO--groups of both ligands form hydrogen bonds with NH2-groups of 
cytosines. NH2-groups of both argininamides, according to the complex geometry, form 
hydrogen bonds with the aromatic nitrogen atoms of guanines. The structure of a 
malachite green molecule contains three aromatic rings. In its complex with an aptamer, 
two rings form two pi-pi bonds with aromatic rings of guanine and cytosine, according 
to their mutual conformation.
Based on the analysis of the NMR experimental data and our own results, we presume 
that stabilization of a ligand inside an aptamer binding site is not always determined by 
h-bonds, pi-pi or cation-pi interactions, even if an aptamer and a ligand have the groups 
that can form such interactions. Therefore, in our opinion, based on the currently 
available data, it is impossible to simplify the approach presented in this paper. We 
assume that it could be possible in future, when more structures of aptamers for small 
molecules are determined experimentally and by applying in silico tools. Statistical 
processing of these data could then help to develop a new, more rational search 
algorithm.
4. Conclusions
Having applied rational in silico design, for the first time we have obtained aptamers 
that could bind paraoxon. We have shown that paraoxon binds to these aptamers more 
efficiently than to the peripheral anionic site of acetylcholinesterase. A similar approach 
could be used to search for aptamers for other OPs. Having analyzed the aptamer-
paraoxon complexes obtained, we conclude that h-bonds, pi-pi or cation-pi interactions 
can help anchoring a ligand by an aptamer, but stabilization of a ligand inside a binding 
site can be due to non-specific van der Waals interaction. Therefore, it is not possible 
currently to predict the structure of aptamers for OPs based on the chemical structure of 
a ligand.
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Caption to figures
Fig. 1. 3D structure of aptamer SS24-S-35 (Zhang et al., 2014) obtained by molecular 
dynamic simulation.
Fig. 2.Possible binding sites of paraoxon inside the aptamer according to molecular 
docking.
Fig. 3. Time dependence of distance between the phosphorus atom of paraoxon and the 
phosphorus atom of a nucleotide at position 19 (as the approximate center of site-1) of 
the studied aptamers according to MD simulation. The values of the distances were 
taken every 100 ps during the simulations.
Fig. 4. Complex of paraoxon with site-1 of aptamer SS24-S-35 obtained by 10 ns 
molecular dynamics simulation.
Fig.5. Paraoxon molecule (presented in balls) bound in the peripheral anionic site (PAS) 
of acetylcholinesterase (AChE, presented as a white/grey surface). Amino acids of PAS 
Tyr72 and Asp74 are presented in sticks. 
Fig. 6. The conformation of the complex of paraoxon (purple) with aptamer SS24-S-35 
(grey) withthe lowest binding energy (Confbest) according to MM-PBSA calculations 
and position of paraoxon (green) obtained by molecular docking into the aptamer in 
theConfbest.
Fig. 7. The complexes of paraoxon with the site-1 of aptamers T17C-C18T (A) and 
T17C (B) according to molecular dynamics data.
Fig. 8.Time dependence of electrostatic (red) and van der Waals (blue) energy of 
interaction of paraoxon with aptamers T17C-C18T (A), T17C (B), C18A (C), 
T20G (D), T19C (E) and C18G (F) according to MM-PBSA calculations.
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Table 1 Result of molecular docking of paraoxon into five possible binding sites of 
aptamer SS24-S-35 (aptamer obtained in Zhang et al. 2014).
Binding 
site
Nucleotides of the 
binding site
Intermolecular 
energy, kcal/mol
Estimated free energy 
of binding, kcal/mol
Site-1 С18, T20 -4.38 -2.29
Site-2 С13, А15, А22, -4.68 -2.59
Site-3 G12, G25, С27 -5.5 -3.41
Site-4 С10, G31 -6.25 -4.16
Site-5 Т5, G33 -6.33 -4.25
Table 2 Contribution of the nucleotides of site-1 (T17, C18, T19, T20) to binding 
energy of the aptamer-paraoxon complex
Energy, kcal/mol T17 C18 T19 T20
MM kcal/mol -4.1±0.7 -2.3±0.5 -6.1±0.5 -3.4±0.9
Polar kcal/mol 0.1±0.6 -0.3±0.7 2.3±0.8 1.3±0.9
SASA kcal/mol -0.3±0.1 -0.1±0.1 -0.4±0.1 -0.3±0.1
Total kcal/mol -4.2±1.4 -2.7±1.2 -4.2±1.5 -2.4±1.8
ММ – potential energy in vacuum, polar – polar solvation energy, SASA – non-polar 
solvation energy, T – thymine, C – cytosine.
Table 3 Free binding energies of the initial paraoxon-aptamer- complex (PAC) and of 
its mutants.
Initial paraoxon-aptamer complex Free binding energy, kcal/mol
PAC (Т17С18Т19T20) -31.0±3.8
Mutation at position 20 Mutation at position 18
Aptamer
Free binding 
energy, kcal/mol
Aptamer
Free binding 
energy, kcal/mol
Т20А -30.7±3.9  С18А  -13.4±16.0
Т20С -27.3±4.0  С18G  -26.6±4.6
Т20G -18.1±11.0  C18T  -30.6±3.6
Mutation at position 19 Mutation at position 17
Aptamer
Free binding 
energy, kcal/mol
Aptamer
Free binding 
energy, kcal/mol
Т19А -25.5±9.9 Т17А -27.5±4.9
Т19С -22.6±6.1 Т17С -32.3±3.0
Т19G -29.4±5.0 Т17G -31.3±3.7
Free biding energies were obtained by molecular docking (MD)
